The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease

被引:4
|
作者
Dalton, Kristen [1 ]
Smith, Maxwell [2 ,3 ]
Thurman, Joshua M. [1 ]
机构
[1] Univ Colorado Denver, Sch Med, Dept Med, Denver, CO 80204 USA
[2] Univ Colorado Denver, Sch Med, Dept Pathol, Aurora, CO USA
[3] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO USA
来源
CLINICAL KIDNEY JOURNAL | 2010年 / 3卷 / 04期
关键词
membranous lupus nephritis; mycophenolate mofetil; transformation;
D O I
10.1093/ndtplus/sfq046
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The transformation of lupus nephritis from one histologic pattern to another is well described. We report a case of a patient who initially presented with diffuse proliferative glomerulonephritis and was treated with prednisone and mycophenolate mofetil (MMF). She initially responded well to therapy, but later developed high-grade proteinuria while still on MMF and low-dose steroids. A repeat biopsy performed after the increase in proteinuria demonstrated that she had focal proliferative disease but that she had also developed membranous lupus nephritis. Our case is unique in that we report a patient who developed membranous lupus nephritis while receiving MMF.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 50 条
  • [1] Mycophenolate mofetil as the primary treatment of membranous lupus nephritis.
    Kasitanon, N
    Petri, M
    Haas, M
    Magder, L
    Fine, D
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S192 - S193
  • [2] Membranous lupus nephritis in a renal allograft: Response to mycophenolate mofetil therapy
    Denton, MD
    Galvanek, EG
    Singh, A
    Sayegh, MH
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (03) : 288 - 292
  • [3] Defining the Role of Mycophenolate Mofetil in the Treatment of Proliferative Lupus Nephritis
    Oliver Dr Lenz
    Alessia Fornoni
    Gabriel Contreras
    [J]. Drugs, 2005, 65 : 2429 - 2436
  • [4] Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis
    Lenz, O
    Fornoni, A
    Contreras, G
    [J]. DRUGS, 2005, 65 (17) : 2429 - 2436
  • [5] Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases
    Kasitanon, N.
    Petri, M.
    Haas, M.
    Magder, L. S.
    Fine, D. M.
    [J]. LUPUS, 2008, 17 (01) : 40 - 45
  • [6] Interest of mycophenolate mofetil in children with membranous lupus nephritis
    Gargah, Tahar
    Goucha-Louzir, Rim
    Lakhoua, Mohamed Rachid
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (07): : 564 - 568
  • [7] Progression of lupus nephritis during treatment with mycophenolate mofetil
    Ahmadi-Simab, K
    Lamprecht, P
    Gross, WL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1179 - 1180
  • [8] Treatment of Lupus Nephritis by Mycophenolate Mofetil
    Rabrenovic, Violeta
    Poskurica, Mileta
    Kovacevic, Zoran
    Nesic, Vidosava
    Savin, Marina
    Mitic, Branka
    Dimkovic, Nada
    Cuckovic, Cedomir
    Vujic, Danica
    Pljesa, Steva
    Perunicic-Pekovic, Gordana
    Curic, Slobodan
    Mitic, Igor
    Ratkovic, Marina
    Marinkovic, Jelena
    Jovanovic, Dragan
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (04): : 297 - 303
  • [9] MYCOPHENOLATE MOFETIL: A POTENTIAL TREATMENT FOR REDUCING PROTEINURIA ASSOCIATED WITH MEMBRANOUS LUPUS NEPHRITIS
    Ferro, M. L.
    Karim, M. Y.
    Abbs, I. C.
    D'Cruz, D. P.
    Khamashta, M. A.
    Hughes, G. R. V.
    [J]. RHEUMATOLOGY, 2003, 42 : 79 - 79
  • [10] Lupus nephritis: treatment with mycophenolate mofetil
    Kapitsinou, PP
    Boletis, JN
    Skopouli, FN
    Boki, KA
    Moutsopoulos, HM
    [J]. RHEUMATOLOGY, 2004, 43 (03): : 377 - 380